pI: 10.0042 |
Length (AA): 680 |
MW (Da): 79862 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 8 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
39 | 680 | 2eyq (A) | 455 | 1001 | 12.00 | 0 | 1 | 0.66 | 0.45 |
451 | 610 | 2g2j (A) | 308 | 471 | 28.00 | 0 | 1 | 0.59 | -2.02 |
1 | 174 | 4tql (A) | 38 | 217 | 10.00 | 0.43 | 0.03 | 0.398382 | -0.93 |
146 | 615 | 4nho (A) | 354 | 797 | 26.00 | 0 | 1 | 0.793576 | 0.01 |
192 | 628 | 4w7s (A) | 184 | 580 | 28.00 | 0 | 1 | 0.797047 | -0.01 |
454 | 572 | 2p6n (A) | 407 | 522 | 37.00 | 0.00000035 | 1 | 0.6614 | -0.63 |
478 | 611 | 2hjv (A) | 236 | 368 | 30.00 | 0.0014 | 1 | 0.691059 | -1.18 |
545 | 614 | 2p6n (A) | 495 | 564 | 31.00 | 0.39 | 0.84 | 0.440941 | -0.38 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, gametocyte, sporozoite, early ring, late ring. | Otto TD PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, merozoite, early schizont, early trophozoite, late trophozoite, Ring, Sporozoite, Female Gametocyte. | Otto TD PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 32 hs, intra-erythrocytic - 48 hs, late schizont, Oocyst. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 40 hs, Male Gametocyte. | Otto TD Lasonder E |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_128422)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G09720 | DEAD-box ATP-dependent RNA helicase 57 |
Babesia bovis | BBOV_IV006910 | DEAD box RNA helicase, putative |
Candida albicans | CaO19.11240 | DEAD box RNA helicase similar to S. cerevisiae ROK1 (YGL171W) required for 18S rRNA synthesis |
Candida albicans | CaO19.3756 | DEAD box RNA helicase similar to S. cerevisiae ROK1 (YGL171W) required for 18S rRNA synthesis |
Caenorhabditis elegans | CELE_R05D11.4 | Protein R05D11.4 |
Cryptosporidium hominis | Chro.60373 | dead box RNA helicase |
Cryptosporidium parvum | cgd6_3210 | Rok1p, eIF4A-1-family RNA SFII helicase |
Dictyostelium discoideum | DDB_G0274325 | DEAD/DEAH box helicase |
Drosophila melanogaster | Dmel_CG5589 | CG5589 gene product from transcript CG5589-RA |
Echinococcus granulosus | EgrG_000511750 | ATP dependent RNA helicase DDX52 |
Echinococcus multilocularis | EmuJ_000511750 | ATP dependent RNA helicase DDX52 |
Giardia lamblia | GL50803_14451 | ATP-dependent RNA helicase |
Homo sapiens | 11056 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 52 |
Leishmania braziliensis | LbrM.32.0650 | ATP-dependent RNA helicase-like protein, putative,RNA helicase, putative |
Leishmania donovani | LdBPK_320600.1 | ATP- dependent RNA helicase, putative |
Leishmania infantum | LinJ.32.0600 | ATP-dependent RNA helicase-like protein, putative,RNA helicase, putative |
Leishmania major | LmjF.32.0570 | ATP-dependent RNA helicase-like protein, putative,RNA helicase, putative |
Leishmania mexicana | LmxM.31.0570 | ATP-dependent RNA helicase-like protein, putative,RNA helicase, putative |
Mus musculus | ENSMUSG00000020677 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 52 |
Neospora caninum | NCLIV_007630 | ATP-dependent RNA helicase, putative |
Oryza sativa | 4344113 | Os07g0647900 |
Plasmodium berghei | PBANKA_0505700 | ATP-dependent RNA helicase ROK1, putative |
Plasmodium falciparum | PF3D7_1021500 | ATP-dependent RNA helicase ROK1, putative |
Plasmodium knowlesi | PKNH_0605800 | ATP-dependent RNA helicase ROK1, putative |
Plasmodium vivax | PVX_001940 | ATP-dependent RNA helicase, putative |
Plasmodium yoelii | PY02253 | putative ATP-dependent RNA helicase c22f3.08c |
Saccharomyces cerevisiae | YGL171W | RNA-dependent ATPase ROK1 |
Schistosoma japonicum | Sjp_0214930 | ko:K01529 similar to ATP-dependent RNA helicase ROK1 isoform a [EC:3.6.1.-], putative |
Schistosoma mansoni | Smp_047110 | DEAD box ATP-dependent RNA helicase |
Schmidtea mediterranea | mk4.000199.04 | Putative dead box ATP-dependent RNA helicase |
Trypanosoma brucei gambiense | Tbg972.11.15430 | ATP-dependent DEAD/H RNA helicase, putative,ATP- dependent RNA helicase, putative |
Trypanosoma brucei | Tb927.11.13810 | ATP- dependent RNA helicase, putative |
Trypanosoma congolense | TcIL3000.11.14180 | ATP- dependent RNA helicase, putative |
Trypanosoma cruzi | TcCLB.509161.130 | ATP- dependent RNA helicase, putative |
Toxoplasma gondii | TGME49_253090 | DEAD/DEAH box helicase domain-containing protein |
Theileria parva | TP03_0216 | RNA helicase, putative |
Trichomonas vaginalis | TVAG_335860 | DEAD box ATP-dependent RNA helicase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.5370 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.5370 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.5370 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.5370 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
YGL171W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_0505700 | Plasmodium berghei | Slow | plasmo |
TGME49_253090 | Toxoplasma gondii | Probably essential | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.3